← Leaderboards
Seung Ha Nam
Weill Medical Coll Of Cornell Univ
$3,570,811
Attributed
$4,651,416
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,651,416 · 3
By mechanism
DP5$2,334,534 · 1
R01$2,161,211 · 1
K08$155,671 · 1
Top collaborators
- Ann Mullally4 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Nicole Kucine$740,011
- Anna Sophia McKenney$192,972
- Tobias Meyer$31,193,700
- Robert M Samstein$4,654,145
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsProgenitorMyelogenousMyeloproliferative DiseaseMutationMutateHematological DiseaseHematopoietic DifferentiationHematopoietic Stem CellsMolecularMultiple OmicsBloodGenesMutantExhibitsGenotypeHematopoieticHematopoiesisCellsCd34 GeneInnovationLinkChromatinProteins
Grant awards (12)
Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells$700,999
R01 · FY2025 · HL · contact PI
Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells - Diversity Supplement$54,859
R01 · FY2025 · HL · contact PI
Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells$686,979
R01 · FY2024 · HL · contact PI
Defining malignant hematopoiesis via single-cell multi-omics$423,750
DP5 · FY2024 · OD · contact PI
Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells$718,374
R01 · FY2023 · HL · contact PI
Defining malignant hematopoiesis via single-cell multi-omics$423,750
DP5 · FY2023 · OD · contact PI
Defining malignant hematopoiesis via single-cell multi-omics$105,197
DP5 · FY2023 · OD · contact PI
Defining malignant hematopoiesis via single-cell multi-omics$423,750
DP5 · FY2022 · OD · contact PI
Defining malignant hematopoiesis via single-cell multi-omics - DP5 diversity supplement application$110,587
DP5 · FY2022 · OD · contact PI
Defining malignant hematopoiesis via single-cell multi-omics$423,750
DP5 · FY2021 · OD · contact PI
Defining malignant hematopoiesis via single-cell multi-omics$423,750
DP5 · FY2020 · OD · contact PI
Integrating genetic, epigenetic, and microenvironmental determinants of myeloproliferative neoplasms via single-cell multi-omics$155,671
K08 · FY2020 · HL · contact PI